Scientists test first-ever therapy to make human cells young again

Live updates

1. 1d ago

   First Human Trial for Cellular Age Reversal Begins

   Life Biosciences has administered the first gene therapy designed to treat optic neuropathies in a living patient. This procedure aims to reprogram old human cells to reverse cellular aging and treat incurable vision loss. Researchers warn that the process carries a risk of cancer.

   What's confirmed:

   • Scientists are attempting to reverse cellular aging in a living patient to treat incurable vision loss.
   • The first participant in a clinical trial to reverse human aging has been treated.

   Still unconfirmed:

   • Life Biosciences conducted the world's first gene therapy for optic neuropathies on June 9.
   • The cellular reprogramming process carries a risk of cancer.
   • Tina Woods claims blood tests show her biological age is 35.
   confidence 80%
2. 5d ago

   First Human Trials Begin for ER-100 Cellular Reprogramming Therapy

   Scientists have started the first human clinical trials for a gene therapy called ER-100. The treatment aims to rejuvenate aging cells to treat age-related eye diseases. Researchers have already treated the first participant in the study.

   What's confirmed:

   • The first human trial of ER-100 gene therapy aims to reprogram aging cells to reverse age-related eye diseases.
   • Researchers have treated the first participant in a clinical trial aimed at cellular reprogramming.

   Still unconfirmed:

   • The therapy may be used specifically for glaucoma treatment.
   • A US company is offering an unapproved gene therapy that increases klotho protein at overseas clinics to avoid FDA rules.
   confidence 90%